AI Article Synopsis
- There is an increasing focus on the hormonal changes in aging males, especially as the male population over 50 is expected to grow.
- Research is centered around conditions like Androgen Decline in the Aging Male (ADAM) and Partial Androgen Deficiency of the Aging Male (PADAM), often referred to as "andropause."
- The International Society for the Study of the Aging Male (ISSAM) has proposed official guidelines for investigating and treating late-onset hypogonadism in men, and this article discusses their recent French translation.
Article Abstract
There is growing interest in the hormonal changes of the ageing male, particularly in view of the expected growth of the population of males over the age of 50. Current research topics essentially concern androgen decline in the aging male (ADAM), or partial androgen deficiency of the aging male (PADAM), commonly called "andropause" in France. Although progress has been made in our knowledge concerning androgen deficiency of the aging male, it is still incomplete, sometimes confused, and some aspects of androgen replacement therapy remain controversial. The International Society for the Study of the Aging Male (ISSAM) therefore considered it appropriate to propose a series of practical and official guidelines concerning the investigation, treatment and surveillance of late-onset hypogonadism in males. The French translation of these recent international guidelines is presented and discussed in this article.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!